Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good morning A$ & LD
$UCLE US Nuclear Corp: It All Started With the Manhattan Project
https://www.newmediawire.com/news/us-nuclear-corp-it-all-started-with-the-manhattan-project-7075679
LOS ANGELES, CA - (NewMediaWire) - June 17, 2024 - US Nuclear (OTC-QB: UCLE) has a rich history, beginning as a spin-off of the Manhattan Project manufacturing the first radiation detectors, and continuing to evolve and expand into the first fusion power tritium monitors, forensic measurement drones, and real-time PFAS monitors.
It all started with the making of the atomic bomb. From June 18, 1942 to August 25, 1947, the Manhattan Project employed over 130,000 people throughout the United States. The top-secret project to develop the atomic bomb forever altered the world we live in.
US Nuclear’s founder was Hugh Glassford, well known for his part in building the major cyclotron accelerator that earned Ernest Lawrence a Nobel prize. The cyclotron was needed to enrich the uranium for the Manhattan Project. Afterwards, Glassford was reassigned to design and build a suite of radiation safety detectors to protect all the staff and the genius physicists such as Einstein, Fermi, Feynman, Seaborg, Teller, and Hans Bethe to name a few.
Suddenly, there was this urgent need for radiation detectors. US Nuclear filled this urgent need for radiation safety equipment, protecting the highly valuable physicists, and becoming the first manufacturer of such equipment. Afterwards, US Nuclear continued to provide essential equipment for key points in history, such as the civil defense for Russian bomb threats during the Cold War, getting the US’s nuclear navy going, as well as the UK’s Rolls-Royce nuclear submarines.
US Nuclear has of course supported nuclear power plants around the world throughout its history. The development of nuclear power is a growing market that is desperately needed to meet the world’s energy demands, and the market is continuing to evolve. There are more green energy nuclear power plants under construction, and new small modular reactor projects like Bill Gates’s Terra Power facility in Wyoming now being built. Nuclear defense and fission-based power is still growing, but could be considered a niche market.
So, looking to multiply their market size, US Nuclear reinvents itself. Fusion power using tritium as its fuel source is coming, and is one of the reasons USN acquired Overhoff Technology, famous tritium monitor manufacturer.
Broadening their markets even more, USN reinvents itself again with instrumented drone monitors, the DroneRAD system, used for airborne measurement of radiation and a wide range of dangerous, toxic or unwanted chemicals including “war gases” and fentanyl. The drone and drone services business is quite scalable with a huge market for individuals, security companies, police, fire and first responders, inspection of solar energy and wind turbine facilities, and much more. USN’s “Climate Drone” has two on-board Methane detectors, and one CO2 detector. One methane detector is laser based and can detect methane at a distance, while the other is a “sniffer” allowing the user to pinpoint and quickly repair the leaks or other sources of gas.
US Nuclear continues to expand, adding sensors for detecting hazardous gases and contaminated water, including the world’s first real-time PFAS monitor, which are sold to civilian, government, and military markets, as well as water utilities.
US Nuclear sells domestically, and in many other countries around the world, a very wide range of innovative sensor systems for contaminants in the air, river water and drinking water, on person’s clothes, in packages, or vehicles, for a wide range of users including hospitals, border crossings, government offices, military facilities, and prisons. In most cases, these sensors are offered for hand-held use, as a doorway or entrance/exit monitor, or as drone-mounted monitors.
US Nuclear loves to be the first to market.
First in 1948 with radiation detectors for personnel, ships, and submarines.
First in 2006 with fusion power tritium monitors.
First in forensic measurement drones.
First in real-time PFAS monitors.
Who knows what great things US Nuclear might do tomorrow?
GM $treet!!
Good morning A$ & LD
Good morning A$ & LD
Good morning A$ & LD
Just that they are working on getting current again with financing.
Have a Great rest of day…………cya all tomorrow
$AVRW News: Avenir Wellness Solutions Reports Fourth Quarter 2023 Results
New Initiatives Showing Encouraging Results
SHERMAN OAKS, CA / ACCESSWIRE / May 17, 2024 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir" or the "Company"), a proprietary broad platform technology and wellness company, today announced results for the fourth fiscal quarter ended December 30, 2023.
Key financial highlights for the fourth quarter included the following:
Net revenue in the fourth quarter of 2023 increased to $1.1 million from the same period in 2022 by $0.2 million, or 11.7%, and also increased sequentially from Q3 2023 by $43 thousand, or 4.4%. Overall growth was lower than expected due to the continued delay in receiving the expected remainder of the asset sale proceeds to be used for advertising and marketing to drive sales. The quarter did, however, benefit from a new relationship with leading online and beauty subscription box retailer, FabFitFun.
Gross margin increased 407 basis points year over year in the fourth quarter of 2023 due to improved working capital management offset in part by a higher proportion of sales coming from our wholesale channel of distribution with its lower margins than our higher-margin direct-to-consumer sales channel.
Gross margin for the third quarter of 2023 decreased sequentially from the second quarter of 2023 by 26 basis points due to a shift in sales channel mix with a higher proportion of wholesale sales to Amazon and FabFitFun which resulted in shipments of approximately $0.3 million.
Cost containment initiatives led to a favorable impact on SG&A expenses (excluding non-cash charges) for the fourth quarter with a decrease of $357 thousand in 2023 compared to 2022 driven by decreased spend on advertising and promotion of $325 thousand lower overhead by $32 thousand.
Net operating loss from continuing operations (excluding non-cash charges) improved by $0.9 million in 2023.
"Our products continue to maintain sales levels which is encouraging given that we have been unable to fully execute on our marketing initiatives pending receipt of the balance of the proceeds from the July 2022 asset sale. As mentioned in our third quarter earnings announcement, the proceeds from the July 2022 asset sale allow us to invest in the future of the Company, but the delay in receiving the balance of the proceeds continued to have an impact on our operating performance. We expect accelerating sales will reaffirm the improving overall trajectory of the business. Further, our margin expansion initiatives continue to deliver results with improvement from third quarter, and we continue our overall cost containment initiatives to further reduce SG&A expenses and to maximize operating leverage.
Fine tuning our Search Engine Optimization (SEO), bringing our media buying in house and achieving successful monthly campaigns like theSkimm continue to deliver for us as we execute on our strategy to build our brands," said Nancy Duitch, Avenir CEO.
Operational Highlights
Other operational highlights during the fourth quarter of 2023 included:
Our newly formulated Seratopical Revolution Cracked Heel Souffle was selected for inclusion in FatFitFun's Summer 2024 subscription box selling out an astonishing 80,000 units in under 43 minutes. Click link to view Instagram videos on our Cracked Heel Souffle.
Our DNA Complex hero product continues to perform as our subscription based grows.
Wholesale sales led by Amazon continue to grow with all the positive product reviews.
We began development of our new TikTok shop to capitalize on the evolving digital ecommerce landscape which launched in the second quarter of 2024.
For further details, please visit our website to review our most recent Form 10-K filed on May 17, 2024 at: http://www.avenirwellness.com/sec-filings/
About Avenir Wellness Solutions, Inc.
Avenir Wellness Solutions, Inc. (OTCQB:AVRW) is a broad platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems which are integrated into our wellness and beauty products and sold directly to the consumer. The technology, which is based on (15) fifteen current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new technologies that is part of its incubator strategy in order to monetize its intellectual property as well as expand our product lines utilizing the technology. As a vertically integrated platform company, Avenir looks to partner or license its IP technology with wellness companies worldwide. For more information visit: http://www.avenirwellness.com.
About The Sera Labs, Inc.
Sera Labs, a wholly owned subsidiary of Avenir, is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting-edge technology. Sera Labs creates high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical™, Seratopical Revolution™, SeraLabs™, and Nutri-Strips™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health and wellness, Sera Labs products are sold direct-to-consumer (DTC) via online website orders, including a subscribe and save option, and also sold online and in-store at major national drug, grocery chains, convenience stores, and mass retailers and on Amazon.com. For more information visit: http://www.seralabshealth.com and follow Sera Labs on Facebook, Instagram and TikTok at @seratopical as well as on X (Twitter) at @sera_labs.
Forward Looking Statement
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which statements are subject to considerable risks and uncertainties. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the future growth and success of our organization. We have attempted to identify forward-looking statements by using words such as "anticipate," "believe," "could," "estimate," "expected," "intend," "may," "plan," "predict," "project," "should," "will," or "would," and similar expressions or the negative of these expressions.
Forward-looking statements represent our management's current expectations and predictions about trends affecting our business and industry and are based on information available as of the time such statements are made. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy or completeness. Forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements predicted, assumed or implied by the forward-looking statements. Some of the risks and uncertainties that may cause our actual results to materially differ from those expressed or implied by these forward-looking statements are described in the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as well as in our Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.
Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable law, we expressly disclaim any intent or obligation to update any forward-looking statements, or to update the reasons actual results could differ materially from those expressed or implied by these forward-looking statements, whether to conform such statements to actual results or changes in our expectations, or as a result of the availability of new information.
CONTACTS:
Investor Relations
Hanover International Inc.
T: (760) 564-7400
E: investor@avenirwellness.com
Good morning A$ & LD
Profitable Jr Gold Miner: $BMXI - .107
Net Revs: $2.4M last Quarter.......
Data From #DDAmanda: Book Value: 0.4226 R: 0.25 | EPS: 0.1 Cash Ratio: 7% | PE Ratio: 1.07
Z
200Day Lows from #DDAmanda:
AIU, ALGS, APLM, CEI, CYBN, DNA, EFSH, GDHG, GETR, GOSS, LUXH, LYRA, MBIO, OPTT, ROMA
Z
Good morning A$ & LD
Gotta Jet Early , Have a GREAT weekend
Good morning A$ & LD
$AAJP .001 first target...Will trade thinner as we move up...
Buzz on X for $AAJP is increasing, can’t imagine this is trips much longer
$AAJP expect .001 to fall within a week
$AAPJ .0005 Primary loading zone here with news coming
Followers
|
2338
|
Posters
|
|
Posts (Today)
|
3
|
Posts (Total)
|
589360
|
Created
|
06/29/07
|
Type
|
Free
|
Moderator $treet Trader | |||
Assistants gumzsa Ask$lapper |
Follow the KING of pennies on Twitter
https://twitter.com/#!/Street__Trader
?
**Please be sure to member mark $treet Trader so that his posts will be highlighted here for you on this thread** >> http://investorshub.advfn.com/boards/addPersonMrk.asp?user=82395 <<
Posts Today
|
3
|
Posts (Total)
|
589360
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |